Revised March 2018
Opioid-Related Overdose Deaths
In 2016, there were 1,130 opioid-related overdose deaths in Virginia—a rate of 13.5 deaths per 100,000 persons—compared to the national rate of 13.3 deaths per 100,000 persons. Since 2010, the number of heroin-related overdose deaths has increased from 45 to 450 deaths—a tenfold increase. Overdose deaths related to synthetic opioids have increased even more dramatically from 87 to 648 deaths.
Opioid Pain Reliever Prescriptions
In 2015, Virginia providers wrote 70 opioid prescriptions per 100 persons (approximately 5.6 million prescriptions), equivalent to the national average (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
In 2016, 773 babies in Virginia were born with NAS, a rate of 8.0 cases per 1,000 births. The average across 28 states included in a separate 2013 analysis was 6.0 cases per 1,000 births (CDC, MMWR, 2014).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 956 occurred in Virginia; with 5.5 percent1 of new cases in males and 5.9 percent of new cases in females attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 21,740 persons were living with a diagnosed HIV infection in Virginia—a rate of 311 infections per 100,000 persons. Of these, 14.5 percent1 of males and 17.0 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Virginia reported 8,138 cases of chronic HCV and 52 cases of acute HCV (0.6 cases per 100,000 persons) (Virginia.gov; CDC).
- State Prevalence: Current state prevalence data are not available. As of 2010, an estimated 66,700 persons (1,090 cases per 100,000 persons) were living with HCV in Virginia (HepVu).
- Virginia Department of Health, Opioid Addiction in Virginia
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Virginia, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH HEAL (Helping to End Addiction Long-term) Initiative
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number.